Thromboelastography: Coagulation Beyond INR and aPTT
Dr. Dhanesh Sukumaran, Critical Care physician in Saveetha Medical College And Hospital, shared a very insightful post on Thromboelastography on LinkedIn:
”Understanding Coagulation Beyond INR and aPTT – The Power of TEG
In the ICU and OR, we often face complex coagulopathies—massive transfusions, sepsis-induced DIC, liver failure, trauma. Traditional labs like INR, aPTT, and platelet count tell only part of the story.
Enter Thromboelastography (TEG) – a dynamic, real-time assessment of the entire clotting cascade, from clot formation to lysis.
What makes TEG valuable?
- Rapid bedside results
- Guides goal-directed transfusion (PRBC, FFP, platelets, cryo, antifibrinolytics)
- Reduces unnecessary blood product use
- Especially useful in trauma, cardiac surgery, liver transplantation, and sepsis-related coagulopathy
Key parameters:
• R-time: Time to clot initiation (think clotting factors)
• K-time and Alpha angle: Speed of clot formation (fibrinogen function)
• MA (Maximum Amplitude): Strength of the clot (platelet function)
• LY30: Clot stability and fibrinolysis
TEG doesn’t replace conventional tests but complements them—giving us the “big picture” in real time.
If you’re not using TEG in your critical care or perioperative practice yet, it’s time to explore its impact.”
Find more comprehensive insights on coagulation in Hemostasis Today.
-
Sep 11, 2025, 08:33Alfonso J. Tafur Shares VascuLearn’s Free Virtual Support Groups This Fall for Patients and Providers
-
Sep 10, 2025, 23:00Blood Vessels, Thrombosis and Hemostasis - Blood VTH and Blood Neoplasia: Now Indexed in PubMed!
-
Sep 10, 2025, 13:00Shivani Modi Presents 7 Posters at SOHO 2025: From AI to Hematologic Emergencies
-
Sep 10, 2025, 09:27Deep Vein Thrombosis (DVT) Explained in One Slide: Causes, Symptoms, Diagnosis and Treatment
-
Sep 10, 2025, 09:20Giuseppe Biondi Zoccai Celebrates Release of New Book on Medical Statistics
-
Sep 11, 2025, 15:03Rapid ADAMTS13 Assays: A Key Milestone in the 100 Years of Innvoation in TTP Diagnosis - Silvio Castagni
-
Sep 11, 2025, 13:55Transplantation-Mediated Alloimmune Thrombocytopenia: Mostafa Faisal Mohammed Saleh Presents a Rare Case
-
Sep 10, 2025, 22:34Nicolas Gendron on The Emerging Role of CLIA in The Diagnosis Strategy for HIT
-
Sep 10, 2025, 21:13Gregory Piazza on The Link Between VTE and Atherothrombosis
-
Sep 10, 2025, 19:00Maria Meritxell Roca Mora: DOACs Show Promise Over VKAs in Kidney Transplant Recipients
-
Sep 9, 2025, 20:15Linking a Single Dominant Antibody to HIT: A Novel Study Led by Ishac Nazy, Donald Arnold, and John G. Kelton
-
Sep 8, 2025, 14:24Von Willebrand Factor as a Therapeutic Target․ From Development to Clinical Application
-
Sep 8, 2025, 02:35Reza Shojaei on the Real Worth of Hemoglobin Oxygen Carriers – HBOCs
-
Sep 7, 2025, 14:16Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge
-
Sep 7, 2025, 14:13Breakthrough in Blood: Cécile Denis and INSERM Team Develop Nanobody Therapy for Type 1 VWD
-
Sep 11, 2025, 15:27Postpartum Haemorrhage: In Kenya, More than 120 Mothers Die for Every 100,000 Live Births
-
Sep 11, 2025, 08:08Al-Ola A Abdallah on MGUS-Related Bleeding Disorders
-
Sep 10, 2025, 19:32Denis Brutus Oduor: Call for Altruism in Blood Donation in Nairobi
-
Sep 9, 2025, 10:34James Douketis Receives the 2025 Distinguished Service Award in General Internal Medicine!
-
Sep 9, 2025, 08:07Hemophilia Federation of America Launches ‘Blood Brothers’ Podcast for Men With Bleeding Disorders